ID   ATRN1_MOUSE             Reviewed;        1378 AA.
AC   Q6A051; Q3UHB0; Q68HV2; Q80VI3; Q8BKS4; Q8K0P5;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   20-MAY-2008, sequence version 2.
DT   03-AUG-2022, entry version 144.
DE   RecName: Full=Attractin-like protein 1;
DE   Flags: Precursor;
GN   Name=Atrnl1; Synonyms=Alp, Atrnl, Kiaa0534;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J;
RA   Duke-Cohan J.S.;
RT   "Identification of full-length mouse attractin-like protein (Atrnl).";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Embryonic tail;
RX   PubMed=15368895; DOI=10.1093/dnares/11.3.205;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S.,
RA   Saga Y., Seino S., Nishimura M., Kaisho T., Hoshino K., Kitamura H.,
RA   Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: IV.
RT   The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 11:205-218(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 690-1237 (ISOFORM 2).
RC   STRAIN=C57BL/6J;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1002-1378 (ISOFORM 1).
RC   STRAIN=Czech II, and FVB/N; TISSUE=Kidney, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH MC4R.
RX   PubMed=14531729; DOI=10.1042/bj20031241;
RA   Haqq A.M., Rene P., Kishi T., Khong K., Lee C.E., Liu H., Friedman J.M.,
RA   Elmquist J.K., Cone R.D.;
RT   "Characterization of a novel binding partner of the melanocortin-4
RT   receptor: attractin-like protein.";
RL   Biochem. J. 376:595-605(2003).
RN   [6]
RP   DISRUPTION PHENOTYPE, AND TISSUE SPECIFICITY.
RX   PubMed=18064672; DOI=10.1002/dvg.20351;
RA   Walker W.P., Aradhya S., Hu C.-L., Shen S., Zhang W., Azarani A., Lu X.,
RA   Barsh G.S., Gunn T.M.;
RT   "Genetic analysis of attractin homologs.";
RL   Genesis 45:744-756(2007).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: May play a role in melanocortin signaling pathways that
CC       regulate energy homeostasis. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with MC4R. {ECO:0000269|PubMed:14531729}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6A051-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6A051-2; Sequence=VSP_033722, VSP_033723;
CC       Name=3;
CC         IsoId=Q6A051-3; Sequence=VSP_033720, VSP_033721;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain, heart, lung, kidney and
CC       liver. In the central nervous system, it is highly expressed in the
CC       dentate gyrus, CA1-3 regions of the hippocampus, and the ventral taenia
CC       tecta. {ECO:0000269|PubMed:18064672}.
CC   -!- DISRUPTION PHENOTYPE: Mice are grossly normal with no alterations of
CC       pigmentation, central nervous system pathology or body weight. In
CC       contrast, constitutive expression of Atrnl1 in mice lacking Atrn
CC       display normal, agouti-banded hairs and significantly delayed onset of
CC       spongiform neurodegeneration, indicating that overexpression of Atrnl1
CC       compensates for loss of Atrn. {ECO:0000269|PubMed:18064672}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD32245.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY688677; AAT99560.1; -; mRNA.
DR   EMBL; AK172967; BAD32245.1; ALT_INIT; mRNA.
DR   EMBL; AK050882; BAC34442.1; -; mRNA.
DR   EMBL; AK147492; BAE27947.1; -; mRNA.
DR   EMBL; BC030872; AAH30872.1; -; mRNA.
DR   EMBL; BC050020; AAH50020.1; -; mRNA.
DR   CCDS; CCDS29928.1; -. [Q6A051-1]
DR   RefSeq; NP_852080.3; NM_181415.4. [Q6A051-1]
DR   AlphaFoldDB; Q6A051; -.
DR   SMR; Q6A051; -.
DR   BioGRID; 230494; 1.
DR   STRING; 10090.ENSMUSP00000076514; -.
DR   GlyGen; Q6A051; 8 sites.
DR   PhosphoSitePlus; Q6A051; -.
DR   MaxQB; Q6A051; -.
DR   PaxDb; Q6A051; -.
DR   PeptideAtlas; Q6A051; -.
DR   PRIDE; Q6A051; -.
DR   ProteomicsDB; 277196; -. [Q6A051-1]
DR   ProteomicsDB; 277197; -. [Q6A051-2]
DR   ProteomicsDB; 277198; -. [Q6A051-3]
DR   Antibodypedia; 52380; 30 antibodies from 12 providers.
DR   DNASU; 226255; -.
DR   Ensembl; ENSMUST00000077282; ENSMUSP00000076514; ENSMUSG00000054843. [Q6A051-1]
DR   GeneID; 226255; -.
DR   KEGG; mmu:226255; -.
DR   UCSC; uc008iai.2; mouse. [Q6A051-1]
DR   UCSC; uc008iaj.1; mouse. [Q6A051-3]
DR   CTD; 26033; -.
DR   MGI; MGI:2147749; Atrnl1.
DR   VEuPathDB; HostDB:ENSMUSG00000054843; -.
DR   eggNOG; KOG1388; Eukaryota.
DR   GeneTree; ENSGT00940000155790; -.
DR   HOGENOM; CLU_003930_0_0_1; -.
DR   InParanoid; Q6A051; -.
DR   OMA; ACDEWKT; -.
DR   OrthoDB; 49565at2759; -.
DR   PhylomeDB; Q6A051; -.
DR   TreeFam; TF321873; -.
DR   BioGRID-ORCS; 226255; 0 hits in 74 CRISPR screens.
DR   ChiTaRS; Atrnl1; mouse.
DR   PRO; PR:Q6A051; -.
DR   Proteomes; UP000000589; Chromosome 19.
DR   RNAct; Q6A051; protein.
DR   Bgee; ENSMUSG00000054843; Expressed in pigmented layer of retina and 228 other tissues.
DR   Genevisible; Q6A051; MM.
DR   GO; GO:0005604; C:basement membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0009887; P:animal organ morphogenesis; IBA:GO_Central.
DR   GO; GO:0016477; P:cell migration; IBA:GO_Central.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IPI:MGI.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IBA:GO_Central.
DR   GO; GO:0009888; P:tissue development; IBA:GO_Central.
DR   CDD; cd03597; CLECT_attractin_like; 1.
DR   CDD; cd00041; CUB; 1.
DR   CDD; cd00055; EGF_Lam; 1.
DR   Gene3D; 2.120.10.80; -; 2.
DR   Gene3D; 2.60.120.290; -; 1.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR034011; Attractin-like_CTLD.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR016187; CTDL_fold.
DR   InterPro; IPR000859; CUB_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR015915; Kelch-typ_b-propeller.
DR   InterPro; IPR002049; LE_dom.
DR   InterPro; IPR002165; Plexin_repeat.
DR   InterPro; IPR016201; PSI.
DR   InterPro; IPR035914; Sperma_CUB_dom_sf.
DR   Pfam; PF00431; CUB; 1.
DR   Pfam; PF07974; EGF_2; 1.
DR   Pfam; PF00053; Laminin_EGF; 1.
DR   Pfam; PF00059; Lectin_C; 1.
DR   Pfam; PF01437; PSI; 2.
DR   SMART; SM00034; CLECT; 1.
DR   SMART; SM00042; CUB; 1.
DR   SMART; SM00181; EGF; 3.
DR   SMART; SM00180; EGF_Lam; 1.
DR   SMART; SM00423; PSI; 5.
DR   SUPFAM; SSF117281; SSF117281; 1.
DR   SUPFAM; SSF49854; SSF49854; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
DR   PROSITE; PS01180; CUB; 1.
DR   PROSITE; PS00022; EGF_1; 3.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS01248; EGF_LAM_1; 1.
DR   PROSITE; PS50027; EGF_LAM_2; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Disulfide bond; EGF-like domain;
KW   Glycoprotein; Kelch repeat; Laminin EGF-like domain; Lectin; Membrane;
KW   Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..51
FT                   /evidence="ECO:0000255"
FT   CHAIN           52..1378
FT                   /note="Attractin-like protein 1"
FT                   /id="PRO_0000334651"
FT   TOPO_DOM        52..1229
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1230..1250
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1251..1378
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          52..90
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          92..208
FT                   /note="CUB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          206..244
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REPEAT          315..364
FT                   /note="Kelch 1"
FT   REPEAT          366..414
FT                   /note="Kelch 2"
FT   REPEAT          426..474
FT                   /note="Kelch 3"
FT   REPEAT          479..530
FT                   /note="Kelch 4"
FT   REPEAT          532..590
FT                   /note="Kelch 5"
FT   REPEAT          591..637
FT                   /note="Kelch 6"
FT   DOMAIN          613..656
FT                   /note="PSI 1"
FT   DOMAIN          665..708
FT                   /note="PSI 2"
FT   DOMAIN          714..759
FT                   /note="PSI 3"
FT   DOMAIN          754..872
FT                   /note="C-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          888..938
FT                   /note="PSI 4"
FT   DOMAIN          941..1011
FT                   /note="PSI 5"
FT   DOMAIN          1013..1058
FT                   /note="Laminin EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00460"
FT   DOMAIN          1059..1107
FT                   /note="Laminin EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00460"
FT   REGION          1287..1324
FT                   /note="Interaction with MC4R"
FT                   /evidence="ECO:0000269|PubMed:14531729"
FT   REGION          1351..1378
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        75
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        173
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        197
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        379
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        703
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        777
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        897
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1156
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        62..78
FT                   /evidence="ECO:0000250"
FT   DISULFID        80..89
FT                   /evidence="ECO:0000250"
FT   DISULFID        92..118
FT                   /evidence="ECO:0000250"
FT   DISULFID        210..220
FT                   /evidence="ECO:0000250"
FT   DISULFID        214..232
FT                   /evidence="ECO:0000250"
FT   DISULFID        234..243
FT                   /evidence="ECO:0000250"
FT   DISULFID        775..871
FT                   /evidence="ECO:0000250"
FT   DISULFID        1013..1021
FT                   /evidence="ECO:0000250"
FT   DISULFID        1015..1027
FT                   /evidence="ECO:0000250"
FT   DISULFID        1030..1039
FT                   /evidence="ECO:0000250"
FT   DISULFID        1042..1056
FT                   /evidence="ECO:0000250"
FT   DISULFID        1059..1068
FT                   /evidence="ECO:0000250"
FT   DISULFID        1061..1075
FT                   /evidence="ECO:0000250"
FT   DISULFID        1077..1087
FT                   /evidence="ECO:0000250"
FT   DISULFID        1090..1105
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..561
FT                   /note="MEPGVRARSGAPQPASPVLWRARPAGGGGASSWLLLDGNSWLLCYGFLYLAL
FT                   YAQVSQSKPCERTGSCFSGRCVNSTCLCDPGWVGDQCQHCQGRFKLTEPSGYLTDGPIN
FT                   YKYKTKCTWLIEGYPNAVLRLRFNHFATECSWDHMYVYDGDSIYAPLVAVLSGLIVPEV
FT                   RGNETVPEVVTTSGYALLHFFSDAAYNLTGFNIFYSINSCPNNCSGHGKCTTSVSVASQ
FT                   VYCECDKYWKGEACDIPYCKANCGSPDHGYCDLTGEKLCVCNDSWQGPDCSLNVPSTES
FT                   YWILPNVKPFSPSVGRASHKAVLHGKFMWVIGGYTFNYSSFQMVLNYNLESSIWNVGAV
FT                   SRGPLQRYGHSLALYQENIFMYGGRMETSDGNVTDELWVFNVRSQSWSTKTPTVLGHSQ
FT                   QYAVEGHSAHIMELDSRDVVMIVIFGYSAIYGYTSSIQEYHISSNTWLVPETKGAIVQG
FT                   GYGHTSVYDEVTKSIYVHGGYKALPGNKYGLVDDLYKYEVNTRTWTILKESGFARYLHS
FT                   AVLINGAMLIFGGNTHNDTSLSNGAKCFSADFLAYDI -> MGWWTTSISTKSTPGL
FT                   (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_033720"
FT   VAR_SEQ         1012..1057
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_033721"
FT   VAR_SEQ         1090..1094
FT                   /note="CDSEN -> YCQFF (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_033722"
FT   VAR_SEQ         1095..1378
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_033723"
FT   CONFLICT        47
FT                   /note="F -> S (in Ref. 1; AAT99560)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        851
FT                   /note="R -> K (in Ref. 4; AAH50020)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        983
FT                   /note="A -> V (in Ref. 2; BAD32245)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1191
FT                   /note="E -> D (in Ref. 4; AAH50020)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1378 AA;  152467 MW;  28E9AE30440E32A7 CRC64;
     MEPGVRARSG APQPASPVLW RARPAGGGGA SSWLLLDGNS WLLCYGFLYL ALYAQVSQSK
     PCERTGSCFS GRCVNSTCLC DPGWVGDQCQ HCQGRFKLTE PSGYLTDGPI NYKYKTKCTW
     LIEGYPNAVL RLRFNHFATE CSWDHMYVYD GDSIYAPLVA VLSGLIVPEV RGNETVPEVV
     TTSGYALLHF FSDAAYNLTG FNIFYSINSC PNNCSGHGKC TTSVSVASQV YCECDKYWKG
     EACDIPYCKA NCGSPDHGYC DLTGEKLCVC NDSWQGPDCS LNVPSTESYW ILPNVKPFSP
     SVGRASHKAV LHGKFMWVIG GYTFNYSSFQ MVLNYNLESS IWNVGAVSRG PLQRYGHSLA
     LYQENIFMYG GRMETSDGNV TDELWVFNVR SQSWSTKTPT VLGHSQQYAV EGHSAHIMEL
     DSRDVVMIVI FGYSAIYGYT SSIQEYHISS NTWLVPETKG AIVQGGYGHT SVYDEVTKSI
     YVHGGYKALP GNKYGLVDDL YKYEVNTRTW TILKESGFAR YLHSAVLING AMLIFGGNTH
     NDTSLSNGAK CFSADFLAYD IACDEWKTLP KPNLHRDVNR FGHSAVVING SMYIFGGFSS
     VLLNDILVYK PPNCKAFRDE ELCRNAGPGI KCVWNKNHCE SWESGNTNNI LRAKCPPKTA
     ATDDRCYRYA DCASCTANTN GCQWCDDKKC ISASSNCSTS VRNYTKCHIR NEQICNKLTS
     CKSCSLNLNC QWDQRQQECQ ALPAHLCGEG WNHVGDACLR INSSRESYDN AKLYCYNLSG
     NLASLTTSKE VEFVLDEIQK FTQQKVSPWV GLRKINISYW GWEDMSPFTN TSLQWLPGEP
     NDSGFCAYLE RAAVAGLKAN PCTSMADGLV CEKPVVSPNQ NARPCKKPCS LRTSCANCTS
     SGMECMWCSS TKRCVDSNAY IISFPYGQCL EWQTATCSPQ NCSGLRTCGQ CLEQPGCGWC
     NDPSNTGRGY CIEGSSRGPM KLAGVHNSDV VLDTSLCPKE KNYEWSFIQC PACQCNGHST
     CINNNVCEQC KNLTTGRQCQ ECMPGYYGDP TNGGQCTACT CGGHANVCHL HTGKCFCTTK
     GIKGDQCQLC DSENRYVGNP LRGTCYYSLL IDYQFTFSLL QEDDRHHTAI NFIANPEQSN
     KNLDISINAS NNFNLNITWS VGSTGGTISG EETPIVSKTN IKEYRDSFSY EKFNFRSNPN
     ITFYVYVSNF SWPIKIQIAF SQHNTIMDLV QFFVTFFSCF LSLLLVAAVV WKIKQTCWAS
     RRREQLLRER QQMASRPFAS VDVALEVGAE QTDFLRGPLE GAPKPIAIEP CAGNRAAVLT
     VFLCLPRGSS GAPPPGQSGL AIASALIDIS QQKPSDNKDK TSGVRNRKHL STRQGTCV
//
